Fact CheckerSign in

NCT07869355Not yet recruiting

BRE-13: Mediterranean Diet

BRE-13: Mediterranean Diet-A Presurgical Window of Opportunity Trial Among Women With Breast Cancer

Source: ClinicalTrials.gov · Last updated 9 Oct 2026

Brief summary (registry, in English)

Explore the effect of MedDiet vs. Usual Diet on circulating and breast tumor fatty acid profiles. The investigators aim to examine impact on tumor biology in newly diagnosed participants.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
1 Oct 2026
Start date
15 Feb 2027
Primary completion date
1 Sept 2028
Lead sponsor
University of Illinois Chicago
Diseases
Obesity
NCT number
NCT07869355

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 15 Feb 2027 to the primary completion date, 1 Sept 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Chronic CKD stage 3+ or currently receiving dialysis treatment;

Other illness

  • Currently following a MedDiet, vegan diet, or dietary restrictions (e.g., religious, food intolerance/allergy) that preclude adoption of a MedDiet;
  • History of GI surgery involving removal of part of the stomach or intestines;
  • Type 1 or Type 2 diabetes;
  • Autoimmune or Inflammatory disease or immunocompromised; and

Other

  • Lack of access to a space to safely store and reheat foods items;
  • Living in facility that provides meals;
  • Cachexia.
    • We will not exclude other neoadjuvant treatments. Adults unable to consent Individuals who are not yet adults (infants, children, teenagers) Pregnant or breastfeeding women Prisoners

Who the study is looking for

  • Age ≥ 18 years;
  • Newly diagnosed stage I-III luminal breast cancer
  • Planned surgical resection at UI Health
  • Ability to speak, read, write, and understand English
  • A Mediterranean Eating Pattern for Americans (MEPA-III) score \<13 indicating that they do not currently follow a MedDiet;
  • ECOG performance status of 0 or 1.

Age in the registry: 18 years to 80 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.